4//SEC Filing
BIOGEN IDEC INC. 4
Accession 0001209191-07-034617
$BIIBCIK 0000875045operating
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 5:09 PM ET
Size
13.2 KB
Accession
0001209191-07-034617
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
GLASSBERG ALAN
Director
Transactions
- Sale
Common Stock
2007-05-30$51.54/sh−20,000$1,030,800→ 1,250 total - Award
Stock Option (right to buy)
2007-05-31+5,950→ 5,950 totalExercise: $52.22Exp: 2017-05-30→ Common Stock (5,950 underlying) - Award
Common Stock
2007-05-31+2,300→ 3,550 total - Exercise/Conversion
Stock Option (right to buy)
2007-05-30−20,000→ 10,000 totalExercise: $31.08From: 2001-01-03Exp: 2010-01-02→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2007-05-30$31.08/sh+20,000$621,666→ 21,250 total
Footnotes (4)
- [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Restricted Stock Units were granted as an award for no consideration. Each Restricted Stock Unit represents the right to receive one share of BIIB common stock.
- [F3]Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
- [F4]Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875045
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 5:09 PM ET
- Size
- 13.2 KB